Last week, the National Academies of Science and Engineering joined forces with the Chinese Academy of Science and the Royal Society of the United Kingdom to host an International Summit on Human Gene Editing in Washington, DC. Top scholars in genetics, bioengineering, ethics, and law debated the merits of human gene editing; however consensus was far from achieved. In fact, the repeated reminders of “unknown unknowns” and references to Brave New World left participants wondering how such disparate opinions could be formed into a single set of guidelines from the summit organizing committee.

The final statement from the organizing committee, released at the conclusion of the summit, signified that this gathering would not be the place where final decisions were made. Instead, the committee used the three days of insightful perspectives to develop a framework for how information should be collected. The point of the summit was not to answer the looming questions surrounding human gene editing; rather, it was to determine what questions to ask—and of whom—in order to begin developing recommendations on how to move forward with this technology.

The mix of individuals in the room reflected the planning committee’s efforts to include—but not be limited to—the “usual” perspectives we often hear about these issues. Speakers included important insights and an excellent overview of the process of gene editing and its development in basic research labs, including input from GSA members Jennifer Doudna (UC Berkeley) and Maria Jasin (Memorial Sloan Kettering Cancer Center), GENETICS Associate Editor George Church (Harvard University), George Daley (Harvard University), Emmanuelle Charpentier (Laboratory for Molecular Infection Medicine Sweden, Helmholtz Centre for Infection Research, Medical School of Hannover, and Max Planck Institute for Infection Biology), Jonathan Weissman (UC San Francisco), and Bill Skarnes (Sanger Institute). Videos of the scientific perspectives they and others shared at the meeting can be found here, but the scientific researchers’ perspective held a common theme: basic research on human gene editing must continue if ever we are to understand the risks and advantages to applying the science for a therapeutic purpose.

There has already been a steady stream of articles on the scientific issues involved with gene editing, so this post will not focus on that, except to emphasize that gene editing is not a new topic: although the technologies continue to evolve, CRISPR-Cas9 is only the latest in a series of advancements that have made this easier to do. In addition, many in the model organism communities have led the way in not only developing these techniques, but in conducting the essential background research that can inform the consideration of the opportunities, risks, and implications of gene editing.

An especially interesting part of the summit was the opportunity for scientists to hear important philosophical and ethical perspectives from leaders across diverse social science fields—voices that they may not typically hear in their daily consumption of news and research, or interactions at conferences.

These voices were introduced in a philosophical debate on human rights and consent in the context of reproduction. John Harris (University of Manchester), vehemently argued that the rights of a future child could not be violated because he or she is not yet born; Hille Haker (Loyola University Chicago) opposed this thinking, calling for a moratorium on human germ line gene editing for at least two years citing the lack of consent of the future child. Marcy Darnovsky (Center for Genetics and Society) reminded the room of the societal implications of germ line editing, warning that parents will want to choose traits that society values most. Sharon Terry (Genetic Alliance) provided the patient perspective stating “we need hope not hype.”  With these talks, the question shifted from can we edit the human germ line to should we?

Representatives from South Africa, Nigeria, Israel, China, Germany, India, and Sweden made the realities of medical tourism clear, calling for global collaboration to inform national laws. They also stressed the importance of recognizing and respecting differences among cultural norms across nations. For example, in Israel parenting a genetically related child is considered a right that is reflected by government financed health care coverage for women to receive unlimited in vitro fertilization (IVF) to produce up to two children. In addition, most couples there agree to genetic screening. Such views could make Israeli society more amenable to a technology that could improve the outcome of IVF. Conversely, Germany has passed national legislation outlawing human germ line gene editing and attaching a five year prison sentence to its violation.

The question of how to ensure equitable access to human gene editing technology was addressed by an outstanding panel of social scientists who drew very clear lines between the introduction of new technologies and therapies and the inequitable means by which they are available to the public. Ruha Benjamin (Princeton University) saliently described existing practices as “trickle down biotechnology.” Catherine Bliss (UCSF), author of Race Decoded, closed the summit by providing the historical context of race in genomic research, serving as an all-too-appropriate bookend to the summit’s opening talks from Alta Charo (University of Wisconsin) and Daniel Kevles (Yale University) on eugenics in America and beyond.

While the Summit served as an excellent opening dialogue, it ended like many scientific experiments: with more questions to answer. Who should have been included in this conversation, but was not? How much basic research is enough to convince the public of the safety of human germ line gene editing? Can the costs of this technology be mitigated for equitable access? Is there a way to govern the use of this technology such that the blurry line between therapy and enhancement is not crossed? It is the charge of a new committee, led by Alta Charo and Richard Hynes (Massachusetts Institute of Technology) to find answers to these questions.

For now, the International Summit on Human Gene Editing planning committee urges the continuation of basic research in this area and calls human germ line editing in the clinic “irresponsible” at this time.

We welcome your opinions in the comment section below.

 

Related Headlines:

, , , , ,

Chloe Poston is the Policy and Communications Manager for the Genetics Society of America where she serves as a liaison to the Public Policy Committee. She has a background in bio-analytical chemistry and science policy.

View all posts by Chloe Poston »

Read more in

  • Thank you, GSA community!

    Thank you for being a member of the Genetics Society of America! As GSA’s current president, I am writing to tell you about Society projects and initiatives that we hope you will find useful in advancing your science and your career. Scientific research is a collaborative and exciting endeavor. Scientific societies like GSA exist to…

  • Collage of 2021 Rosalind Franklin Award recipients

    Where are they now? Rosalind Franklin Young Investigator Award recipients share updates on their research

    Rosalind Franklin Young Investigator Award applications are open–make sure you submit your application or nomination of a colleague by September 30, 2024.

  • University of Minnesota researchers map genome of the last living wild horse species

    The study, published in G3: Genes|Genomes|Genetics, is part of larger conservation efforts to save Przewalski’s horse.

  • Congratulations to the Spring 2024 DeLill Nasser Awardees!

    GSA is pleased to announce the recipients of the DeLill Nasser Award for Professional Development in Genetics for Spring 2024! Given twice a year to graduate students and postdoctoral researchers, DeLill Nasser Awards support attendance at meetings and laboratory courses. The award is named in honor of DeLill Nasser, a long-time GSA supporter and National Science Foundation…

  • Carolyn Damilola headshot

    Carolyn Damilola: an NFS Rising Scientist on a lifelong quest to learn more

    Carolyn Damilola is an NFS Rising Scientist from Nigeria doing respiratory system research and paving the way for scientists from underrepresented communities through mentorship.

  • Text over a blue background image: Apply for up to $2,000 for your project from the Starter Culture Microgrant Program.

    What does a good microgrant proposal look like?

    Members of the Microgrant Review Committee share their tips for a successful proposal.

  • A blurred image of a human face is shown against a dark background.

    The first piece of the facial recognition puzzle

    New research in GENETICS gives a first peek at the molecular pathway involved in recognizing faces.

  • New Senior Editor Amy MacQueen joins GENETICS

    A new senior editor is joining GENETICS in the Genome Integrity and Transmission section. We’re excited to welcome Amy MacQueen to the editorial team.

  • Close up of an adult zebrafish with blue and white stripes in an aquarium with red lighting.

    Block party on the zebrafish sex chromosome

    Research in G3 identifies a gene regulatory block of the zebrafish genome responsible for overseeing the maternal-to-zygotic-transition.

  • Lemna Minor, the common duckweed

    Unraveling the mysteries of duckweed: epigenetic insights from Spirodela polyrhiza

    Research published in G3 offers insight into the impact of DNA methylation on clonal propagation in asexually reproducing plants.

  • Luciano Marraffini headshot

    A microbiologist’s quest to understand CRISPR in bacterial self-defense

    2024 Genetics Society of America Medal recipient Luciano Marraffini determined how CRISPR-Cas systems destroy genetic targets with precision, paving the way for gene editing technology development.

  • Elaine Ostrander headshot

    Unlocking mysteries of trait and disease heritability in dogs

    2024 Edward Novitski Prize recipient Elaine Ostrander, a pioneer of the domestic dog model, discovered numerous genes affecting dog size, morphology, behavior, and disease susceptibility—many of which have relevance in humans.

  • NSF-funded BIO-LEAPS Grant to Support Culture Change in Genetics

    GSA and collaborators Personal Genetics Education & Dialogue and Reclaiming STEM Institute launch NSF-funded BIO-LEAPS project to support culture change in genetics 

    We are thrilled to announce that the Genetics Society of America (GSA) is collaborating with the Personal Genetics Education & Dialogue (PGED) based in the Department of Genetics at Harvard Medical School, and the Reclaiming STEM Institute (RSI) on a Leading Culture Change Through Professional Societies of Biology (BIO-LEAPS) grant from the U.S. National Science…

  • Daman Saluja: Navigating Science and Policy in India

    In the Paths to Science Policy series, we talk to individuals who have a passion for science policy and are active in advocacy through their various roles and careers. The series aims to inform and guide early career scientists interested in science policy. This series is brought to you by the GSA Early Care­er Scientist…

  • Deborah Andrew headshot

    A fly geneticist’s journey into discovering rules of organ development

    2024 George W. Beadle Award recipient Deborah Andrew discovered new genes and pathways in Drosophila salivary gland organogenesis. Now, her work can help optimize cell secretion in therapeutic applications and fight malaria.

  • Małgorzata Gazda's headshot

    Małgorzata Gazda: How receiving the DeLill Nasser Award helped her land her dream job

    Have you ever experienced an event that changes the course of your life, or in this case, your career? Małgorzata (Gosia) Gazda is Assistant Professor at the University of Montreal and in 2022, she received the DeLill Nasser Award for Professional Development in Genetics, which she used to attend and present at the 2022 Population,…

  • Hongyu Zhao joins GENETICS as new Senior Editor

    A new senior editor is joining GENETICS in the Statistical Genetics and Genomics section. We’re excited to welcome Hongyu Zhao to the editorial team.

  • Julio Molina Pineda at TAGC 2024

    GSA Member Julio Molina Pineda Receives DeLill Nasser Award, Shines at TAGC 2024 

    “At any career stage, the GSA membership is an amazing investment for any genetics professional!” Julio Molina Pineda is a PhD Candidate in Cell and Molecular Biology and a Research Assistant at the University of Arkansas, and a Doctoral Academy Fellow at the Lewis Lab. In 2023, Julio was awarded the DeLill Nasser Award for…

  • Ed Grell at his dissecting microscope using ether to anesthetize his flies.

    In Memoriam: Ellsworth Herman Grell (1932–2023), a pioneer of Drosophila genome engineering and annotation

    Ellsworth (Ed) Grell blessed the Drosophila community through three enduring legacies: as a pioneer of chromosome mechanics, as a primary organizer and synthesizer of genetic knowledge in Drosophila, and as a graceful mentor to those fortunate to have known him personally. Ed grew up in rural Nebraska, completed his undergraduate studies at Iowa State, and…

  • Congratulations to the #Fungal24 Poster Award winners!

    We are pleased to announce the recipients of the GSA Poster Awards for posters presented at the 32nd Fungal Genetics Conference! Undergraduate and graduate student members of GSA were eligible for the awards, and a hard-working team of judges made the determinations. Congratulations to all! Felicia Ebot Ojong, The University of Georgia My research is focused…

  • Poster presentation tips for TAGC 2024

    You’ve been selected to present a poster at The Allied Genetics Conference 2024 in March—you’ve celebrated, made plans to attend, now what? This is an exciting opportunity to showcase your research and engage with fellow members of the genetics community, so you want to make sure you’re prepared. We wanted to offer you some tips…

  • Maximize your TAGC 2024 experience 

    A guide to all that National Harbor & DC have to offer Are you joining us for The Allied Genetics Conference 2024 in March? Make the most of your #TAGC24 experience in National Harbor! We know the science will keep you busy, but you deserve to unwind and have some fun, so we’ve curated a…

  • Early Career Leadership Spotlight: Sarah Petrosky

    We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah PetroskyMultimedia SubcommitteeUniversity of Pittsburgh Research Interest I am interested in understanding adaptation that has been happening recently in populations by dissecting the ways that genes underlying an adaptation…

  • TAGC 2024 Early Career Award Winners

    GSA is pleased to announce the winners of the early career awards presented at The Allied Genetics Conference 2024. These awards are specific to particular TAGC communities and recognize early career scientists’ outstanding work on their respective research organisms. The awardees will present their talks in keynote sessions at TAGC 2024.  Don’t miss the opportunity…

  • Preeminent geneticists recognized with revamped GSA Awards

    In 2022, GSA’s Board of Directors launched an audit to review the five major awards conferred by the Society. Today, we are thrilled to announce the recipients of the reimagined GSA Awards, including the new Genetics Society of America Early Career Medal. The scientists honored this year are recognized by their peers for their outstanding…

  • Fly Board funds outreach programs to spread the word about Drosophila research

    In 2020, the Fly Board voted to use part of its reserve fund to support efforts to increase trainee participation as well as equity and diversity in the Drosophila community. An awards committee decides how the money will be spent each year, and from 2020–2022, the committee posted a very broad call for applications from…

  • New members of the GSA Board of Directors: 2024–2026

    We are pleased to announce the election of four new leaders to the GSA Board of Directors: 2024 Vice President/2025 President Brenda Andrews Professor, University of Toronto It’s an honor to continue my association with the Society by serving as Vice President of the Board of Directors. I have broad knowledge of the ongoing activities…

  • A tail of three regulatory elements: insights into the structure of C. elegans Raf/LIN-25

    A new paper in GENETICS shows the distal tail segment Raf/LIN-45 downregulates signaling and models its function in other Raf proteins.

  • New members of the GSA Board of Directors: 2025–2027

    We are pleased to announce the election of six new leaders to the GSA Board of Directors: 2025 Vice President/2026 President Cassandra Extavour Timken Professor of Organismic & Evolutionary Biology and of Molecular & Cellular Biology, Harvard University, and Howard Hughes Medical Institute Investigator “Read this,” he said, “it will change your life.” My undergraduate…

  • Congratulations, Spring 2025 Victoria Finnerty Travel Award recipients!

    The Victoria Finnerty Undergraduate Travel Award supports conference-attendance costs for undergraduate GSA members who are presenting research at the Annual Drosophila Research Conference. #Dros25 will be held in San Diego, CA from March 19–23, 2025. Victoria Finnerty, who died in February 2011, was a long-time member of the Genetics Society of America and served the Drosophila community and the genetics community at large in…